ArticleBMC cancer2025

STARKAP Protocol: preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV associated Kaposi's Sarcoma.

Claudia A M Fulgenzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.